Essentials of Psychopharmacology provides a synopsis and update of the most clinically relevant material included within its parent publication, The American Psychiatric Publishing Textbook of Psychopharmacology, a classic that has been hailed as indispensable to psychiatry residents and clinicians alike. This new third edition of the Essentials incorporates the latest research and treatment advances and presents key information in an accessible and easy-to-use manner. The chapter authors are among the foremost national authorities in their areas of expertise, and the content has been thoroughly referenced and meticulously edited for maximum utility.
Among the features of this third edition are the following:
Commonsense organization that takes the reader through the various classes of psychotropic medications (with chapters focused on individual drugs in each class) to treatment using those drugs (with chapters addressing drug selection and therapeutic approaches to the treatment of patients with major psychiatric disorders). Complete information on each drug's clinical pharmacology, pharmacokinetics, approved indications, dosages, side effects and toxicology, and drug-drug interactions. Comprehensive coverage of the current psychotropic pharmacopoeia, including new chapters on the recently introduced antipsychotics asenapine, iloperidone, and lurasidone and updated chapters reflecting further accumulation of experience with other medications. Extensive and thoroughly updated information on the use of psychotropic medications during pregnancy and lactation.
Clinicians seeking a reliable reference and guide to the core knowledge base and practice of clinical psychopharmacology can do no better than this new edition of Essentials of Psychopharmacology.
Alan F. Schatzberg, M.D., is Kenneth T. Norris Jr. Professor of Psychiatry and Behavioral Sciences at the Stanford University School of Medicine in Stanford, California. Charles B. Nemeroff, M.D., Ph.D., is Leonard M. Miller Professor and Chairman of the Department of Psychiatry and Behavioral Sciences at the University of Miami Miller School of Medicine in Miami, Florida.
ContributorsPrefacePART I: Classes of Psychiatric Treatments: Animal and Human Pharmacology Antidepressants and AnxiolyticsChapter 1. Tricyclic and Tetracyclic DrugsChapter 2. FluoxetineChapter 3. SertralineChapter 4. ParoxetineChapter 5. FluvoxamineChapter 6. Citalopram and S-CitalopramChapter 7. Monoamine Oxidase InhibitorsChapter 8. Trazodone and NefazodoneChapter 9. BupropionChapter 10. MirtazapineChapter 11. Venlafaxine and DesvenlafaxineChapter 12. Duloxetine and MilnacipranChapter 13. BenzodiazepinesChapter 14. BuspironeChapter 15. Classic Antipsychotic MedicationsChapter 16. ClozapineChapter 17. OlanzapineChapter 18. QuetiapineChapter 19. AripiprazoleChapter 20. Risperidone and PaliperidoneChapter 21. ZiprasidoneChapter 22. LurasidoneChapter 23. AsenapineChapter 24. IloperidoneChapter 25. Drugs to Treat Extrapyramidal Side EffectsChapter 26. LithiumChapter 27. ValproateChapter 28. Carbamazepine and OxcarbazepineChapter 29. Gabapentin and PregabalinChapter 30. LamotrigineChapter 31. TopiramateChapter 32. Cognitive EnhancersChapter 33. Sedative-HypnoticsChapter 34. Psychostimulants and Wakefulness-Promoting AgentsPART II: Psychopharmacological TreatmentChapter 35. Treatment of DepressionChapter 36. Treatment of Bipolar DisorderChapter 37. Treatment of SchizophreniaChapter 38. Treatment of Anxiety DisordersChapter 39. Treatment of Substance-Related DisordersChapter 40. Treatment of Child and Adolescent DisordersChapter 43. Psychopharmacology During Pregnancy and LactationIndex